\-\ Texto\\:\\ \ \(0\)\
\-\ oral\\ course\\ of\\ metronidazole\\ or\\ vancomycin\\.\ \(0\)\
\-\ diffuse\\ bowel\\ wall\\ thickening\\ of\\ entire\\ colon\\,\\ demonstrating\\ \\"accordion\\ sign\\,\\"\\ \\(oral\\ contrast\\ trapped\\ between\\ markedly\\ thickened\\ haustral\\ folds\\)\\.\\ \\ pericolonic\\ ascites\\ and\\ mild\\ pericolonic\\ stranding\\.\ \(0\)\
\-\ pseudomembranous\\ colitis\ \(3\)\
\-\ inflammatory\\ colitis\ \(0\)\
\-\ radiation\\ enteritis\ \(0\)\
\-\ hypoproteinemia\ \(1\)\
\-\ leukemia\\/lymphoma\ \(1\)\
\-\ ischemic\\ colitis\ \(5\)\
\-\ bowel\\ wall\\ hemorrhage\\ \\(henoch\\-schonlein\\ disease\\)\ \(0\)\
\-\ fever\\,\\ abdomenal\\ pain\\,\\ leukocytosis\\,\\ foul\\-\\ smelling\\ diarrhea\\ after\\ course\\ of\\ antibiotics\\ for\\ treatment\\ of\\ pneumonia\\.\ \(0\)\
\-\ in\\ approximately\\ half\\ the\\ cases\\ of\\ pmc\\,\\ pancolitis\\ will\\ be\\ present\\ \\(not\\ expected\\ in\\ ischemia\\,\\ hemorrhage\\,\\ inflammatory\\ bowel\\ disease\\)\\.\\ \\ hypoproteinemia\\ would\\ show\\ other\\ hollow\\ viscus\\ thickening\\.\\ radiation\\ enteritis\\ would\\ correspond\\ to\\ the\\ radiated\\ port\\.\\ pmc\\ is\\ confirmed\\ by\\ stool\\ assay\\ for\\ c\\.\\ dificile\\ toxin\\.\\ \\ \ \(0\)\
\-\ ct\\ findings\\ do\\ not\\ necessarily\\ correlate\\ with\\ clinical\\ severity\\ and\\ negative\\ ct\\ findings\\ do\\ not\\ exclude\\ pmc\\,\\ thus\\ a\\ high\\ degree\\ of\\ clinical\\ suspicion\\ must\\ be\\ maintained\\ since\\ delayed\\ diagnosis\\ may\\ be\\ fatal\\.\ \(0\)\
\-\ the\\ patient\\ in\\ the\\ above\\ example\\ had\\ a\\ ct\\ 2\\ weeks\\ before\\ the\\ prior\\ study\\,\\ showing\\ pneumonia\\,\\ but\\ normal\\ appearance\\ of\\ bowel\\.\\ \\ after\\ development\\ of\\ pmc\\ \\(presumably\\ from\\ antibiotic\\ tx\\)\\,\\ she\\ was\\ treated\\ with\\ antibiotics\\ \\(flagyl\\)\\,\\ with\\ significant\\ improvement\\ in\\ clinical\\ parameters\\,\\ allowing\\ discharge\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pmc\\:\\ 0\\.3626691385914013\ \(0\)\
\-\ hypoproteinemia\\:\\ 0\\.2244335937799283\ \(0\)\
\-\ colitis\\:\\ 0\\.21786475674577158\ \(0\)\
\-\ bowel\\:\\ 0\\.18850598128168025\ \(0\)\
\-\ pericolonic\\:\\ 0\\.1847725345171453\ \(0\)\
\-\ enteritis\\:\\ 0\\.1755894051531752\ \(0\)\
\-\ clinical\\:\\ 0\\.1396164530627751\ \(0\)\
\-\ do\\:\\ 0\\.1217312392890422\ \(0\)\
\-\ oral\\:\\ 0\\.11762653399001442\ \(0\)\
\-\ dificile\\:\\ 0\\.11743644941056983\ \(0\)\
\-\ pneumonia\\:\\ 0\\.11592258191047164\ \(0\)\
\-\ of\\:\\ 0\\.11496517749685267\ \(0\)\
\-\ accordion\\:\\ 0\\.10851339448966332\ \(0\)\
\-\ course\\:\\ 0\\.10848408911304783\ \(0\)\
\-\ antibiotics\\:\\ 0\\.10820063860791339\ \(0\)\
\-\ abdomenal\\:\\ 0\\.1056408124184006\ \(0\)\
\-\ pancolitis\\:\\ 0\\.1056408124184006\ \(0\)\
\-\ would\\:\\ 0\\.10396471681869628\ \(0\)\
\-\ assay\\:\\ 0\\.10329374196905765\ \(0\)\
\-\ thickening\\:\\ 0\\.09991628986807219\ \(0\)\
\-\ haustral\\:\\ 0\\.09959033956875683\ \(0\)\
\-\ hollow\\:\\ 0\\.09959033956875683\ \(0\)\
\-\ inflammatory\\:\\ 0\\.09931046205373181\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.09833138993497141\ \(0\)\
\-\ flagyl\\:\\ 0\\.09807408944845196\ \(0\)\
\-\ radiation\\:\\ 0\\.09732652115972373\ \(0\)\
\-\ smelling\\:\\ 0\\.0967177574974941\ \(0\)\
\-\ viscus\\:\\ 0\\.09549080600325527\ \(0\)\
\-\ toxin\\:\\ 0\\.09549080600325527\ \(0\)\
\-\ metronidazole\\:\\ 0\\.0933402774949996\ \(0\)\
\-\ parameters\\:\\ 0\\.0933402774949996\ \(0\)\
\-\ pseudomembranous\\:\\ 0\\.09238626725857264\ \(0\)\
\-\ trapped\\:\\ 0\\.09149810497688841\ \(0\)\
\-\ correspond\\:\\ 0\\.09066728464785033\ \(0\)\
\-\ necessarily\\:\\ 0\\.09066728464785033\ \(0\)\
\-\ be\\:\\ 0\\.08936733126452187\ \(0\)\
\-\ wall\\:\\ 0\\.08934111910699004\ \(0\)\
\-\ vancomycin\\:\\ 0\\.0877947025765876\ \(0\)\
\-\ not\\:\\ 0\\.08696961649824582\ \(0\)\
\-\ radiated\\:\\ 0\\.08656775108234877\ \(0\)\
\-\ fatal\\:\\ 0\\.08599551255945638\ \(0\)\
\-\ presumably\\:\\ 0\\.08544763212724464\ \(0\)\
\-\ ct\\:\\ 0\\.08387068038446738\ \(0\)\
\-\ port\\:\\ 0\\.08346321233766614\ \(0\)\
\-\ allowing\\:\\ 0\\.08346321233766614\ \(0\)\
\-\ maintained\\:\\ 0\\.08134809856174308\ \(0\)\
\-\ correlate\\:\\ 0\\.08096379399092853\ \(0\)\
\-\ tx\\:\\ 0\\.08059063026640341\ \(0\)\
\-\ leukocytosis\\:\\ 0\\.08022797960663897\ \(0\)\
\-\ folds\\:\\ 0\\.0791975700534874\ \(0\)\
\-\ ascites\\:\\ 0\\.07574414147032285\ \(0\)\
\-\ the\\:\\ 0\\.0732634053482165\ \(0\)\
\-\ stool\\:\\ 0\\.0732298836440354\ \(0\)\
\-\ example\\:\\ 0\\.0732298836440354\ \(0\)\
\-\ in\\:\\ 0\\.07307167074447425\ \(0\)\
\-\ findings\\:\\ 0\\.07248493830782368\ \(0\)\
\-\ severity\\:\\ 0\\.07242504364083657\ \(0\)\
\-\ after\\:\\ 0\\.07124776909738363\ \(0\)\
\-\ exclude\\:\\ 0\\.07095221092116151\ \(0\)\
\-\ suspicion\\:\\ 0\\.0697886745654276\ \(0\)\
\-\ diarrhea\\:\\ 0\\.06947467736262318\ \(0\)\
\-\ half\\:\\ 0\\.06916815699875929\ \(0\)\
\-\ antibiotic\\:\\ 0\\.06872164124053576\ \(0\)\
\-\ thus\\:\\ 0\\.06746811956744449\ \(0\)\
\-\ entire\\:\\ 0\\.06682108654941635\ \(0\)\
\-\ expected\\:\\ 0\\.06620502416434086\ \(0\)\
\-\ discharge\\:\\ 0\\.06584905916927303\ \(0\)\
\-\ stranding\\:\\ 0\\.06573255840055582\ \(0\)\
\-\ ischemic\\:\\ 0\\.06494530240102524\ \(0\)\
\-\ markedly\\:\\ 0\\.06483666675983785\ \(0\)\
\-\ degree\\:\\ 0\\.06420342859224913\ \(0\)\
\-\ improvement\\:\\ 0\\.06410085237554829\ \(0\)\
\-\ ischemia\\:\\ 0\\.06359988460679063\ \(0\)\
\-\ showing\\:\\ 0\\.06340483167699225\ \(0\)\
\-\ must\\:\\ 0\\.06292975019703768\ \(0\)\
\-\ thickened\\:\\ 0\\.06194246714011315\ \(0\)\
\-\ disease\\:\\ 0\\.06164970470369921\ \(0\)\
\-\ development\\:\\ 0\\.06070766371084346\ \(0\)\
\-\ demonstrating\\:\\ 0\\.06055162244171668\ \(0\)\
\-\ before\\:\\ 0\\.05936704042209591\ \(0\)\
\-\ delayed\\:\\ 0\\.057463712220875506\ \(0\)\
\-\ colon\\:\\ 0\\.05591361183893134\ \(0\)\
\-\ confirmed\\:\\ 0\\.054147387901490235\ \(0\)\
\-\ since\\:\\ 0\\.05319337766506327\ \(0\)\
\-\ above\\:\\ 0\\.05297628572297964\ \(0\)\
\-\ sign\\:\\ 0\\.05083901152434683\ \(0\)\
\-\ fever\\:\\ 0\\.04978898025164513\ \(0\)\
\-\ cases\\:\\ 0\\.04939183059306325\ \(0\)\
\-\ study\\:\\ 0\\.04897497670760335\ \(0\)\
\-\ between\\:\\ 0\\.047713650701394\ \(0\)\
\-\ will\\:\\ 0\\.04726388453358774\ \(0\)\
\-\ approximately\\:\\ 0\\.04685603900559127\ \(0\)\
\-\ show\\:\\ 0\\.04661739319349972\ \(0\)\
\-\ diffuse\\:\\ 0\\.04605201004331784\ \(0\)\
\-\ treated\\:\\ 0\\.0457292309118155\ \(0\)\
\-\ negative\\:\\ 0\\.045462292567184884\ \(0\)\
\-\ for\\:\\ 0\\.0445143728900453\ \(0\)\
\-\ appearance\\:\\ 0\\.04427032274415678\ \(0\)\
\-\ weeks\\:\\ 0\\.04401024830109319\ \(0\)\
\-\ she\\:\\ 0\\.04371332334359323\ \(0\)\
\-\ with\\:\\ 0\\.043137700936129626\ \(0\)\
\-\ significant\\:\\ 0\\.042398992236039795\ \(0\)\
\-\ high\\:\\ 0\\.04173489529118781\ \(0\)\
\-\ mild\\:\\ 0\\.041627468405596044\ \(0\)\
\-\ prior\\:\\ 0\\.04108627595366323\ \(0\)\
\-\ other\\:\\ 0\\.03813529176453297\ \(0\)\
\-\ diagnosis\\:\\ 0\\.03806750199711834\ \(0\)\
\-\ present\\:\\ 0\\.03768120900364898\ \(0\)\
\-\ may\\:\\ 0\\.03695414597733341\ \(0\)\
\-\ had\\:\\ 0\\.036587361990487705\ \(0\)\
\-\ but\\:\\ 0\\.03631307214853149\ \(0\)\
\-\ contrast\\:\\ 0\\.03567992837723449\ \(0\)\
\-\ treatment\\:\\ 0\\.03498036084105195\ \(0\)\
\-\ by\\:\\ 0\\.031184201755772405\ \(0\)\
\-\ and\\:\\ 0\\.030348344058344443\ \(0\)\
\-\ normal\\:\\ 0\\.02998248132927394\ \(0\)\
\-\ from\\:\\ 0\\.029164746550195724\ \(0\)\
\-\ pain\\:\\ 0\\.026277275068942993\ \(0\)\
\-\ was\\:\\ 0\\.02559236636683347\ \(0\)\
\-\ or\\:\\ 0\\.02554627153988164\ \(0\)\
\-\ patient\\:\\ 0\\.02388429138506526\ \(0\)\
\-\ is\\:\\ 0\\.02011031363797734\ \(0\)\
\-\ to\\:\\ 0\\.01835827708792403\ \(0\)\
